Algert Global’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.12M Sell
111,258
-248,560
-69% -$8.15M 0.05% 588
2025
Q4
$13.5M Buy
359,818
+91,210
+34% +$3M 0.21% 124
2025
Q3
$7.4M Sell
268,608
-880
-0.3% -$30.3K 0.12% 281
2025
Q2
$8.52M Buy
269,488
+55,650
+26% +$1.79M 0.18% 168
2025
Q1
$7.1M Sell
213,838
-17,070
-7% -$612K 0.18% 167
2024
Q4
$7.95M Buy
230,908
+139,967
+154% +$4.81M 0.19% 159
2024
Q3
$3.64M Sell
90,941
-11,670
-11% -$410K 0.1% 358
2024
Q2
$3.1M Sell
102,611
-25,000
-20% -$752K 0.1% 325
2024
Q1
$4.29M Sell
127,611
-32,530
-20% -$1.04M 0.17% 200
2023
Q4
$5.17M Buy
160,141
+124,456
+349% +$3.47M 0.21% 131
2023
Q3
$1.17M Sell
35,685
-4,730
-12% -$164K 0.06% 532
2023
Q2
$1.42M Buy
40,415
+26,750
+196% +$923K 0.06% 520
2023
Q1
$446K Sell
13,665
-3,728
-21% -$170K 0.02% 856
2022
Q4
$958K Buy
17,393
+2,390
+16% +$131K 0.05% 587
2022
Q3
$664K Sell
15,003
-282
-2% -$13.8K 0.04% 717
2022
Q2
$745K Sell
15,285
-9,996
-40% -$450K 0.06% 600
2022
Q1
$1.23M Buy
+25,281
New +$1.03M 0.08% 431

Other funds holding HRMY